In-hospital outcomes of acute pulmonary embolism in patients with gastrointestinal cancer: A nationwide study.

Authors

null

SAJANA POUDEL

John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

SAJANA POUDEL , Manoj Ghimire , Kalpana Ghimire , Ayusha Poudel , Karun Shrestha , Prakriti Subedi , Sandesh Karki , Anurag Adhikari , Wendy Tatiana Garzon_Siatoya , Humera Batool , Khaled Elfert , Muhammad Bilal Ibrahim

Organizations

John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, St. Barnabas Hospital, Bronx, NY, St. Barnabas Hospital, New York, NY, UHS SoCal MEC, Temecula, CA, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, Mercy Fitzgerald Hospital, Darby, PA

Research Funding

No funding sources reported

Background: Cancer is a well-established risk factor for the development of pulmonary embolism (PE), especially the. gastrointestinal (GI) cancers. While multiple studies have reported the burden of PE in cancer patients, recent data comparing in-hospital outcomes among different types of cancer patients are lacking. This study aimed to investigate the clinical and healthcare utilization outcomes of hospitalized patients with acute PE in the context of gastrointestinal (GI) cancers. Methods: A cross-sectional study was conducted using data from the National Inpatient Sample (2016-2020). International Statistical Classification of Diseases (ICD-10) codes were employed to identify hospitalized patients admitted with primary diagnosis acute PE. Data regarding GI cancer diagnosis along with demographic information, baseline clinical characteristics, and outcome variables, including mortality, hospital length of stay, total hospital charges, complications and risk factors were collected and analyzed. Statistical analysis was performed using the survey procedures function in STATA v.17, with statistical significance defined by the t-test at a significance level of p < 0.05. Results: Among the 181,060 patients admitted with primary diagnosis of acute pulmonary embolism, 550 (0.3%) had underlying gastric cancer, 1,790 (0.98%) had pancreatic cancer, 875 (0.48%) had hepatobiliary cancer, and 2,600 (1.61%) had small intestine and colorectal cancer. Mortality was found to be significantly higher in all types of GI cancer, with gastric cancer demonstrating the highest mortality rate (10%). After adjusting for age, sex, race, payment category, comorbidities, and risk factors of PE, gastric cancer (OR 2.6; 95% CI: 1.1-6.2) and pancreatic cancer (OR 2.2; 95% CI: 1.4-3.4) were found as independent risk factors for mortality. There was no significant difference in mean length of hospital stays and mean total hospital charges in patients with or without cancer. Similarly, no significant differences were observed in complications such as requirement for mechanical ventilation, arrhythmia, cardiac arrest, need for vasopressor and thrombolysis. Conclusions: In-hospital mortality in patients with acute pulmonary embolism is significantly higher in all types of GI cancer, however; there is no significant differences in hospital length of stay and total hospital charges in patients with or without cancer.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 624)

DOI

10.1200/JCO.2024.42.3_suppl.624

Abstract #

624

Poster Bd #

J11

Abstract Disclosures

Similar Abstracts

First Author: Jayla Hsiung

Abstract

2024 ASCO Annual Meeting

Cancer in Southeast Asia: A comparative analysis of 2022 incidence and mortality data.

First Author: Edward Christopher Christopher Dee

Abstract

2023 ASCO Annual Meeting

Risk factors for in-hospital mortality in cancer patients hospitalized for COVID-19.

First Author: Ziad Abuhelwa

First Author: Can Jones